Artificial Intelligence In Drug Repurposing Market Is Projected To Grow Robustly By 2033
Artificial intelligence is transforming the pharmaceutical industry by making drug repurposing faster, more accurate, and significantly more cost effective than traditional drug discovery methods. Instead of developing entirely new drugs, researchers are increasingly using AI algorithms to identify new therapeutic uses for existing medicines. This approach shortens development timelines, reduces research costs, and increases the likelihood of successful clinical outcomes. The growing adoption of machine learning, deep learning, and predictive analytics is helping pharmaceutical companies analyze vast biological datasets, identify hidden drug-disease relationships, and accelerate clinical research. As demand for faster treatment development increases, AI-driven drug repurposing is becoming a strategic priority for both public and private healthcare organizations. Market Overview According to Grand View Research, the global artificial intelligence in drug repurposing market was va...